Price movement over the last 24 hours
Acadia Healthcare Company Inc vs Northrop Grumman Corporation — how do they compare? Acadia Healthcare Company Inc trades at $30.67 (market cap $2.94B), while Northrop Grumman Corporation trades at $544.81 (market cap $77.98B). The key difference: Northrop Grumman Corporation is far larger — about 26.5× Acadia Healthcare Company Inc's market cap, and Northrop Grumman Corporation pays a 1.71% dividend while Acadia Healthcare Company Inc pays none. Which is the better fit depends on your goals.
| ACHC | NOC | |
|---|---|---|
Market Cap | $2.94B | $77.98B |
Sector | Health | Industrials |
52-Week High | $31.92 | $768.02 |
52-Week Low | $11.68 | $496.02 |
Enterprise Value | $5.45B | $92.21B |
Dividend Yield | — | 1.71% |
Signals from Pluang's Aura AI — not financial advice
ACHC trades at $31.09, down 2.57% today but maintains a bullish technical outlook with strong moving average support. The company shows operational strength with three consecutive earnings beats, though profitability remains challenged with a -32.84% net margin. Analyst consensus is strongly bullish with 68% buy ratings, while recent news highlights the company's strategic shift toward profitability and rising behavioral health demand.
The stock presents a mixed opportunity with strong technical momentum and analyst support offset by persistent profitability challenges. Key catalysts include continued earnings outperformance and successful execution of the turnaround strategy, while risks center on margin pressures and high short interest that could limit upside potential.
Northrop Grumman (NOC) trades at $549.04, showing minimal daily movement. The stock exhibits a bullish technical trend, supported by strong fundamentals including a 10.8% net income margin and consistent earnings beats. Recent news highlights contract wins and positive defense sector sentiment. Analyst consensus is strongly bullish with a $694.40 price target, indicating significant upside potential from current levels.
The outlook remains positive given the company's $95.61B backlog and stable cash flow generation. Key risks include political budget uncertainty and execution challenges. With solid institutional support and improving profitability metrics, NOC presents a compelling opportunity for investors seeking defense sector exposure, though geopolitical developments require monitoring.
Trailing returns across standard periods
Latest headlines on both assets
Acadia Healthcare is a leading provider of behavioral healthcare services across the US and Puerto Rico. It operates a network of psychiatric hospitals, residential treatment centers, and clinics for mental health and addiction recovery.
Read more on ACHC →Northrop Grumman is a defense contractor that is diversified across short-cycle and long-cycle businesses. The firm's segments include aeronautics, mission systems, defense services, and space systems. The company's aerospace segment creates the fuselage for the massive F-35 program and produces various piloted and autonomous flight systems. Mission systems creates a variety of sensors and processors for defense hardware. The defense systems segment is a long-range missile manufacturer. Finally, the company's space systems segment produces various space structures, sensors, and satellites.
Read more on NOC →